The company was started by Peter Foley to connect customers to laboratories for home health testing. To date, the company has raised about $12 million in a Series A led by Optum Ventures in March 2018. The company develops home test kits for general health, sexual health, fertility, and cancer scree...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research


Company Snapshot | August 04, 2021

The company was started by CEO Alexander Bisignano and Santiago Munne in 2016; it has raised $18 million in funding to date, including $8 million from its most recent round in 2020. The company develops GeneCompass, a consumer genetic testing kit for preventative and holistic care, based on next‑... To read more, click here.

ProPhase Labs acquires consumer genomics company Nebula Genomics in $14.6 million deal

News Commentary | August 17, 2021

ProPhase Labs is a medical science technology company that develops molecular testing and lab processing techniques. The company plans to integrate Nebula's whole‑exome sequencing services with its own clinical diagnostic services. The move serves to orient Nebula's next‑generation sequencing ... Not part of subscription

NovogeneAIT Genomics

Company Profile | April 29, 2022

NGS vendor providing high‑throughput genome sequencing services in a College of American Pathologists (CAP)‑certified laboratory and liquid biopsy‑based cancer diagnostics Core differentiation lies in having access to a strong IP portfolio in NGS processes and analyses and providing services in... Not part of subscription